(Q34035703)
Statements
1 reference
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life (English)
1 reference
Alan S Perelson
1 reference
Harel Dahari
1 reference
Libin Rong
1 reference
Natasha D Sansone
1 reference
Richard E Nettles
1 reference
Scott J Cotler
1 reference
Thomas J Layden
1 reference
Susan L Uprichard
1 reference
19 February 2013
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference